Xenogeneic thymus transplantation in a pig-to-baboon model

被引:23
作者
Wu, A
Yamada, K
Neville, DM
Awwad, M
Wain, JC
Shimizu, A
Gojo, S
Kitamura, H
Colvin, RB
Cooper, DKC
Sykes, M
Sachs, DH
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02115 USA
[2] NIH, Bethesda, MD 20892 USA
[3] Immerge Bio Therapeut, Charlestown, MA USA
[4] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Thorac Surg, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1097/01.TP.0000044137.97841.99
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background We have tested whether fetal porcine thymic tissue transplantation can lead to tolerance across a discordant (pig-to-baboon) xenogeneic barrier. Methods. Six baboons underwent a conditioning regimen with thymectomy, splenectomy, and anti-monkey CD3 antibody conjugated to a diphtheria toxin binding site mutant (FN18-CRM9). Porcine fetal or neonatal thymic tissue was transplanted into three baboons. Three control baboons received either no transplanted pig tissue (n=1) or adult pig lymph node (n=2). Cellular responses and skin xenografts were used to test for tolerance. Results. Experimental baboons: After T-cell depletion and thymic transplantation, recovery of thymus-dependent naive-type CD4 cells (CD4/CD45RA(high)) and in vitro xenogeneic hyporesponsiveness were observed. No sensitization of alpha-galactosyl antibody responses was observed. The thymic grafts survived up to 48 days. Porcine skin xenografts were performed in two of these animals with survival of 22 and 24 days. Control baboons: Only two of these animals were completely T-cell depleted, and both failed to recover thymus-dependent T cells (CD4/CD45RA(high)). In one animal, general in vitro hyporesponsiveness was observed, with subsequent death from infection. The second animal demonstrated delayed recovery of T cells and prolonged general hyporesponsiveness in vitro. Neither animal demonstrated prolongation of porcine skin grafts compared with allografts (both rejected by day 13). Conclusions. Porcine thymic tissue is able to induce xenogeneic hyporesponsiveness. More efficient thymic engraftment may allow this approach to induce xenograft tolerance.
引用
收藏
页码:282 / 291
页数:10
相关论文
共 21 条
[1]  
BARTH RN, IN PRESS XENOGENIC T, V1
[2]   Split tolerance induced by immunotoxin in a rhesus kidney allograft model [J].
Fechner, JH ;
Vargo, DJ ;
Geissler, EK ;
Graeb, C ;
Wang, J ;
Hanaway, MJ ;
Watkins, DI ;
Piekarczyk, M ;
Neville, DM ;
Knechtle, SJ .
TRANSPLANTATION, 1997, 63 (09) :1339-1345
[3]  
Haller GW, 1999, J IMMUNOL, V163, P3785
[4]   Effective T cell regeneration following high-dose chemotherapy rescued with CD34+ cell enriched peripheral blood progenitor cells in children [J].
Heitger, A ;
Kern, H ;
Mayerl, D ;
Maurer, K ;
Nachbaur, D ;
Frühwirth, M ;
Fink, FM ;
Niederwieser, D .
BONE MARROW TRANSPLANTATION, 1999, 23 (04) :347-353
[5]   Essential role of the thymus to reconstitute naive (CD45RA(+)) T-helper cells after human allogeneic bone marrow transplantation [J].
Heitger, A ;
Neu, N ;
Kern, H ;
PanzerGrumayer, ER ;
Greinix, H ;
Nachbaur, D ;
Niederwieser, D ;
Fink, FM .
BLOOD, 1997, 90 (02) :850-857
[6]   Thymus-independent expansion of T lymphocytes in children after allogeneic bone marrow transplantation [J].
Honda, K ;
Takada, H ;
Nagatoshi, Y ;
Akazawa, K ;
Ohga, S ;
Ishii, E ;
Okamura, J ;
Hara, T .
BONE MARROW TRANSPLANTATION, 2000, 25 (06) :647-652
[7]  
KAWAI T, 1994, TRANSPLANT P, V26, P1845
[8]   Anti-Galα1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction [J].
Kozlowski, T ;
Monroy, R ;
Xu, YX ;
Glaser, R ;
Awwad, M ;
Cooper, DKC ;
Sachs, DH .
TRANSPLANTATION, 1998, 66 (02) :176-182
[9]   SPECIFIC TOLERANCE ACROSS A DISCORDANT XENOGENEIC TRANSPLANTATION BARRIER [J].
LEE, LA ;
GRITSCH, HA ;
SERGIO, JJ ;
ARN, JS ;
GLASER, RM ;
SABLINSKI, T ;
SACHS, DH ;
SYKES, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :10864-10867
[10]  
Markert ML, 1997, J IMMUNOL, V158, P998